Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Population-Based Pragmatic Prostate Cancer Screening Trial Based on PSA, Kallikrein Panel, and MRI

NCT03423303 is registered in ClinicalTrials.gov with Tampere University as lead sponsor.

NCT NCT03423303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03423303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Population-Based Pragmatic Prostate Cancer Screening Trial Based on PSA, Kallikrein Panel, and MRI
Lead sponsor
Tampere University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 23, 2018
Completion date
December 31, 2037
Enrollment
17,400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer